Retrospective study: real-world risk of suicidal ideation with semaglutide
In this medfyle
There have been reports of suicidal ideation with semaglutide – a worrying pattern that follows other historical weight-loss drugs, and which has triggered regulatory agency investigations. This real-world cohort from the US explores the risks with semaglutide compared to other kinds of weight-loss and anti-diabetes medications.
About this Medfyle
©2024 Medfyle. All rights reserved.
Original article: Wang W, Volkow ND, Berger NA, Davis PB, Kaelber DC, Xu R. Association of semaglutide with risk of suicidal ideation in a real-world cohort. Nat Med. 2024 Jan;30(1):168-176. doi: 10.1038/s41591-023-02672-2. Epub 2024 Jan 5. PMID: 38182782.
The summary content was prepared by Marie Farrow for Medfyle, and reviewed by Marco Comoglio, MD.
The authors of the original article and the publisher were not involved in the creation of the summary.
